Viewing StudyNCT04923204



Ignite Creation Date: 2024-05-06 @ 4:15 PM
Last Modification Date: 2024-10-26 @ 2:06 PM
Study NCT ID: NCT04923204
Status: COMPLETED
Last Update Posted: 2021-06-11
First Post: 2021-05-03

Brief Title: Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression
Sponsor:
Organization: AB Biotics SA

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 76
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
76283
Who Masked List: